Saturday, October 17, 2026 · Edition updated 6:00 AM ETSAT, OCT 17 · 6 AM ET editionNext edition in Next --:--:--

A single knee injection of UBX0101 was tested in people with knee arthritis

Completed · PHASE 2 · Unity Biotechnology, Inc.

What this means

This study tested one shot of UBX0101 directly into the knee joint. It checked whether the shot helped pain and whether it was safe, but this summary does not give the results.

Plain-English summary written by an AI model from the registry listing.

Status
Completed
Who can join
Ages 40–85
Where
20 sites, including Alabama, Arizona, California

Contacts and how to join ↗

The science

Registered title
A Study to Assess the Safety and Efficacy of a Single Dose of UBX0101 in Patients With Osteoarthritis of the Knee
Phase
PHASE 2
Study type
interventional
Conditions
Osteoarthritis, Knee
What is tested
UBX0101, Placebo
Sponsor
Unity Biotechnology, Inc.
Ages
40 Years to 85 Years
Dates
First posted Oct 17, 2019 · updated Dec 29, 2021

Registry summary

A study to assess efficacy, safety, and tolerability of a single-dose intra-articular administration of UBX0101 in patients with moderate to severe painful knee osteoarthritis (OA).

Sites (20)

  • Central Research Associates, Birmingham, Alabama, United States
  • Coastal Clinical Research, LLC., Mobile, Alabama, United States
  • Fiel Family and Sports Medicine, Tempe, Arizona, United States
  • Tucson Orthopaedic Institute, Tucson, Arizona, United States
  • Biosolutions Clinical Research Center, La Mesa, California, United States
  • Diablo Clinical Research, Walnut Creek, California, United States
  • Charter Research, Lady Lake, Florida, United States
  • Well-Pharma Medical Research, Miami, Florida, United States
  • Precision Clinical Research, Sunrise, Florida, United States
  • Premier Medical Associates, The Villages, Florida, United States
  • Chicago Clinical Research Institute, Chicago, Illinois, United States
  • The Alliance for Multispecialty Research, Wichita, Kansas, United States
  • Alliance for Multispecialty Research-Lexington, Lexington, Kentucky, United States
  • The Alliance for Multispecialty Research, Kansas City, Missouri, United States
  • Hassman Research Institute, Berlin, New Jersey, United States

And 5 more on the listing.

More aging trials in these states

Alabama · Arizona · California · Florida · Illinois · Kansas · Kentucky · Missouri · New Jersey · New Mexico · New York · Pennsylvania · South Carolina

Report a problem